Do you want to read an article? Please log in or register.
Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026)
Genitourinary Cancer
Related content
Genitourinary Cancer
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Eur Urol
Karpinski MJ, Rahbar K, Bögemann M, Nikoukar LR, Schäfers M, Hoberück S, Miederer M, Hölscher T, Rasul S, Miszczyk M, Lanfranchi F, Bauckneht M, Pfob CH, Kind F, Goffin K, Hüsing A, Kesch C, Herrmann K, Stuschke M, Gafita A, Hüsing J, Calais J, Hofman MS, Hope TA, Miksch J, Soeterik TFW, Di Giorgio A, Farolfi A, Bjartell A, Trägårdh E, Unterrainer LM, Holzgreve A, Sheikh GT, Rauscher I, Eiber M, Hadaschik BA, Fendler WP
doi: 10.1016/j.eururo.2025.04.017
COMMENTED
Genitourinary Cancer
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
J Clin Oncol
Garje R, Riaz IB, Naqvi SAA, Rumble RB, Taplin ME, Kungel TM, Herchenhorn D, Zhang T, Beckermann KE, Vapiwala N, Carducci MA, Celano P, Hotte SJ, Basu A, Borno H, Bryce AH, Wang P, Wulff-Burchfield E, Bodei L, Loblaw A, Hamilton RJ, Emamekhoo H, Hope TA, He H, Murad MH, Liu H, Williams JE Jr, Parikh RA
doi: 10.1200/JCO-25-00007
Genitourinary Cancer
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
J Natl Compr Canc Netw
Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan A, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan T, Pessoa R, Rais-Bahrami S, Roach M 3rd, Robin T, Rosenfeld S, Scarpato KR, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D
doi: 10.6004/jnccn.2025.0052
Genitourinary Cancer
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial
Eur Urol
Vigneswaran HT, Palsdottir T, Micoli C, Tilki D, Lin D, Cooperberg M, Eggener S, Falagario UG, Möller A, Aly M, Akre O, Wiklund P, Egevad L, Grönberg H, Nordström T, Eklund M
doi: 10.1016/j.eururo.2025.10.001
Genitourinary Cancer
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1
J Clin Oncol
Taplin ME, Riaz IB, Rumble RB, Naqvi SAA, Hope TA, Dias MF, He H, Hotte SJ, Emamekhoo H, Murad MH, Celano P, Kungel TM, Hentzen S, Serzan MT, Parikh RA
doi: 10.1200/JCO-25-02693
Genitourinary Cancer
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model
Prostate Cancer Prostatic Dis
Siech C, von Kriegstein H, Wenzel M, Cano Garcia C, Le QC, Tennstedt P, Preisser F, Maurer T, Kriegmair M, Chun FKH, Graefen M, Tilki D, Mandel P
doi: 10.1038/s41391-025-01018-y
Further Publications
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer
Eur J Cancer
Sandherr M, Schalk E, Heinz WJ, Köhler P, Krause SW, Liss B, Kausche L, Link H, Mellinghoff SC, Schmidt-Hieber M, Schuelper N, Spiekermann K, Sprute R, Seggewiss-Bernhardt R
doi: 10.1016/j.ejca.2026.116244
Genitourinary Cancer
Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis
Eur Urol
Strieder de Oliveira G, Altmayer S, Torri GB, Prediger JE, Abreu-Gomez J, Ghai S, Haider MA, Ghezzi CLA, Andrade RGF, Ponsiglione A, Brembilla G, Giganti F, Asif A, Ng ABCD, Kasivisvanathan V, Dias AB
doi: 10.1016/j.eururo.2026.01.030
Genitourinary Cancer
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer
Prostate Cancer Prostatic Dis
Morgans AK, Wallis CJD, Halabi S, Armstrong AJ, Adorjan P, Ghadessi M, Verholen F, Grimm MO
doi: 10.1038/s41391-026-01076-w